The University of Southampton
University of Southampton Institutional Repository

Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis

Raia, V., Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Auricchio, S., Cimmino, M., Cavaliere, M., Nardone, M., Cesaro, A., Malcolm, J., Quaratino, S. and Londei, M. (2005) Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis Thorax, 60, (9), pp. 773-780. (doi:10.1136/thx.2005.042564).

Record type: Article


Background: Cystic fibrosis (CF) airways are characterised by chronic inflammation, increased interleukin (IL)-8 secretion, and neutrophil activation which are considered the principal factors of morbidity and mortality in CF patients. Optimising management of this chronic inflammatory response is therefore a key issue of basic and clinical CF research. Several reports have addressed ways to manage CF airways inflammation, and an attractive therapeutic strategy may be the inhibition of the p38-mitogen activated protein kinase (p38-MAP-k) pathway.
Methods: A new ex vivo model was used to study the mucosal inflammatory response to environmental airways stimuli. Nasal biopsy tissues from CF patients and controls were cultured ex vivo for 20 minutes, 4 hours, and 24 hours in the presence of lipopolysaccharide (LPS) from Pseudomonas aeruginosa (PA) with and without the p38-MAP-k inhibitor SB203580. Quantitative mRNA assessment, immunohistochemistry, and Western blots were used to detect the expression and modulation of inflammatory markers.
Results: PA-LPS challenge induced a time dependent mucosal inflammation indicated by rapid epithelial activation, IL-8 release, COX-2 upregulation, and neutrophil migration to the upper mucosal layers. Some of these LPS induced changes (IL-8 release and neutrophil migration) were specific to CF tissues. SB203580 significantly controlled all LPS induced mucosal changes in CF tissues.
Conclusion: These findings provide a rationale and proof of principle for the potential use of p38-MAP-k inhibitors to control inflammation in patients with CF.

Full text not available from this repository.

More information

Published date: 2005
Keywords: interleukin 8, neutrophil, inflammation, cystic fibrosis, mitogen activated protein kinase


Local EPrints ID: 26550
ISSN: 0040-6376
PURE UUID: bf99c962-be21-428f-8ca0-3a76f1b2aa0e

Catalogue record

Date deposited: 20 Apr 2006
Last modified: 17 Jul 2017 16:07

Export record



Author: V. Raia
Author: L. Maiuri
Author: C. Ciacci
Author: I. Ricciardelli
Author: L. Vacca
Author: S. Auricchio
Author: M. Cimmino
Author: M. Cavaliere
Author: M. Nardone
Author: A. Cesaro
Author: J. Malcolm
Author: S. Quaratino
Author: M. Londei

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.